scholarly article | Q13442814 |
P2093 | author name string | Sibley JT | |
Sundaram MB | |||
Olszynski WP | |||
Decoteau WE | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systemic lupus erythematosus | Q1485 |
central nervous system disease | Q5062122 | ||
nervous system | Q9404 | ||
P304 | page(s) | 47-52 | |
P577 | publication date | 1992-01-01 | |
P1433 | published in | The Journal of Rheumatology | Q7743623 |
P1476 | title | The incidence and prognosis of central nervous system disease in systemic lupus erythematosus | |
P478 | volume | 19 |
Q35740915 | Antibody induction of lupus-like neuropsychiatric manifestations |
Q36332517 | Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus |
Q33712381 | Brainstem Reflexes in Systemic Lupus Erythematosus Patients Without Clinical Neurological Manifestations. |
Q37019825 | Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus |
Q33566332 | Cerebellum and brainstem vasculopathy in systemic lupus erythematosus: two clinico-pathological cases |
Q64997838 | Clinical features and prognoses of acute transverse myelitis in patients with systemic lupus erythematosus. |
Q33567067 | Controversies in lupus: nervous system involvement |
Q24200954 | Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus |
Q55234314 | Definition of NPSLE: Does the ACR Nomenclature Still Hold? |
Q38186995 | Diagnosis and management of neuropsychiatric SLE. |
Q35549279 | Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET |
Q34079262 | Diminished white matter integrity in patients with systemic lupus erythematosus |
Q50785654 | Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center. |
Q27477927 | Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature |
Q35185887 | Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus |
Q37468127 | Is it relevant to screen young women hospitalized in psychiatric department for neuropsychiatric systemic lupus erythematosus (NPSLE)?: A prospective study of 100 psychiatric inpatients |
Q58043494 | Kardiovaskuläre und pupilläre autonome und somatosensible Neuropathie bei chronischen Erkrankungen mit Autoimmunphänomenen |
Q92605937 | Longitudinally Extensive Transverse Myelitis Associated With Systemic Lupus Erythematosus: A Case Report and Literature Review |
Q71978570 | Lupus transverse myelopathy: better outcome with early recognition and aggressive high-dose intravenous corticosteroid pulse treatment |
Q97645687 | Meningitis as the initial manifestation of systemic lupus erythematosus |
Q33862215 | Neurobrucellosis in systemic lupus erythematosus |
Q34250901 | Neuropsychiatric lupus |
Q37922765 | Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management |
Q34075832 | Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience |
Q40506590 | Prognosis in systemic lupus erythematosus |
Q35226381 | Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration |
Q37638315 | Reduced Insular Glutamine and N-acetylaspartate in systemic lupus erythematosus: a single-voxel (1)H-MR spectroscopy study |
Q38087564 | Secondary psychoses: an update |
Q36307414 | Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study |
Q40506580 | Systemic lupus erythematosus--disease management |
Q40371891 | Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction |
Q38889566 | The role of B cells and autoantibodies in neuropsychiatric lupus |
Q37029059 | Treatment of Posterior Reversible Encephalopathy Syndrome that Occurred in a Patient with Systemic Lupus Erythematosus by Plasmapheresis |
Search more.